Rectifying function, restoring hope

Developing disease-modifying precision therapeutics for patients with serious genetic diseases


About us

Rectify is developing Positive Functional Modulators (PFMs), disease-modifying precision therapeutics that restore ABC transporter function for patients with serious genetic diseases.

ABC transporters are a 48-member family of membrane-bound proteins with etiologic loss-of-function mutations in multiple organ systems and therapeutic areas including the lungs, liver, gastrointestinal tract, eye, and central nervous system.

Our team


Rajesh Devraj, Ph.D.

President and Chief Executive Officer

Jonathan Moore, Ph.D.

Founder and Chief Scientific Officer

Tracey Dawson, Ph.D.

Chief Operating Officer

Janeta Popovici-Muller, Ph.D.

Senior Vice President, Head of Drug Discovery

Alastair Garfield, Ph.D.

Senior Vice President, Head of Biology

Scientific Advisory Board

Richard Chesworth, DPhil

Independent R&D Consultant

Bob Copeland, Ph.D.

Co-Founder and CSO, Accent Therapeutics

Richard Thompson, BM BCh, DM

Professor of Molecular Hepatology, School of Immunology & Microbial Sciences at King’s College London

Jamie Williamson, Ph.D.

Professor, Department of Integrative Structural and Computational Biology, Scripps Research Institute

Board of Directors

Jason Rhodes

Executive Chairman, Partner, Atlas Venture

Rajesh Devraj, Ph.D.

President and CEO, Rectify Pharmaceuticals

Marco Boorsma, Ph.D.

General Partner, Forbion

Jonathan Moore, Ph.D.

Founder and CSO, Rectify Pharmaceuticals

Otello Stampacchia, Ph.D.

Founder and Managing Partner, Omega Funds

David Steinberg, MBA

General Partner, Longwood Fund

Jodie Morrison

Venture Partner, Atlas Venture


Join us

We are a team of passionate, driven scientists and biotech leaders, united in our vision to restore hope to individuals and families affected by serious genetic disease.

Rectify Pharma is looking for motivated individuals to join our growing team. Please click here to see our current openings or email for more information.

Contact us

400 Technology Square
Second floor, Suite 201
Cambridge, MA 02139